The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy
Abstract
SUMMARY: Diabetic peripheral neuropathy (DPN) affects up to 50% of patients with diabetes and is a major cause of morbidity and increased mortality. Its clinical manifestations include painful neuropathic symptoms and insensitivity, which increases the risk for burns, injuries and foot ulceration. Several recent studies have implicated poor glycaemic control, duration of diabetes, hyperlipidaemia (particularly hypertryglyceridaemia), elevated albumin excretion rate s and obesity as risk factors for the development of DPN. Although there is now strong evidence for the importance of nerve microvascular disease in the pathogenesis of DPN, the risk factors for painful DPN are not known. However, emerging evidence regarding the central correlates of painful DPN is now afforded by brain imaging. The diagnosis of DPN begins with a careful history of sensory and motor symptoms. The quality and severity of neuropathic pain if present should be assessed using a suitable scale. Clinical examination should include inspection of the feet and evaluation of reflexes and sensory responses to vibration, light touch, pinprick and the 10‐g monofilament. Glycaemic control and addressing cardiovascular risk is now considered important in the overall management of the neuropathic patient. Pharmacological treatment of painful DPN includes tricyclic compounds, serotonin–norepinephrine reuptake inhibitors (e.g. duloxetine), anticonvulsants (e.g. pregabalin), opiates, membrane stabilizers, the antioxidant alpha lipoic acid and others. Over the past 7 years, new agents with perhaps less side effect profiles have immerged. Management of patients with painful neuropathy must be tailored to individual requirements and will depend on the presence of other co‐morbidities. There is limited literature with regard to combination treatment. Copyright © 2012 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tesfaye, S., Boulton, A. J. M., Dyck, P. J., Freeman, R., Horowitz, M., Kempler, P., Lauria, G., Malik, R. A., Spallone, V., Vinik, A., et al. (2010) · Diabetes Care · doi:10.2337/dc10-1303 · Cited by 2,690
Self-citationThe Cerebral Signature for Pain Perception and Its Modulation
Tracey, I., & Mantyh, P. W. (2007) · Neuron · doi:10.1016/j.neuron.2007.07.012 · Cited by 1,843
Vascular risk factors and diabetic neuropathy
Tesfaye, S., Chaturvedi, N., Eaton, S. E. M., Ward, J. D., Manes, C., Ionescu-Tirgoviste, C., Witte, D. R., & Fuller, J. H. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa032782 · Cited by 1,323
Self-citationFrom the gate to the neuromatrix
Melzack, R. (1999) · Pain · doi:10.1016/s0304-3959(99)00145-1 · Cited by 1,170
The Prevalence, Severity, and Impact of Painful Diabetic Peripheral Neuropathy in Type 2 Diabetes
Davies, M., Brophy, S., Williams, R., & Taylor, A. (2006) · Diabetes Care · doi:10.2337/dc05-2228 · Cited by 746
Pain perception: Is there a role for primary somatosensory cortex?
Bushnell, M. C., Duncan, G. H., Hofbauer, R. K., Ha, B., Chen, J.-I., & Carrier, B. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.14.7705 · Cited by 735
The Health Care Costs of Diabetic Peripheral Neuropathy in the U.S.
Gordois, A., Scuffham, P., Shearer, A., Oglesby, A., & Tobian, J. A. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1790 · Cited by 734
Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy
Cameron, N. E., Eaton, S. E. M., Cotter, M. A., & Tesfaye, S. (2001) · Diabetologia · doi:10.1007/s001250100001 · Cited by 701
Self-citationTesfaye, S., Stevens, L. K., Stephenson, J. M., Fuller, J. H., Plater, M., Ionescu-Tirgoviste, C., Nuber, A., Pozza, G., & Ward, J. D. (1996) · Diabetologia · doi:10.1007/s001250050586 · Cited by 695
Self-citationNeuropathic Diabetic Foot Ulcers
Boulton, A. J. M., Kirsner, R. S., & Vileikyte, L. (2004) · New England Journal of Medicine · doi:10.1056/nejmcp032966 · Cited by 592
Treatment of symptomatic diabetic polyneuropathy with the antioxidant α‐lipoic acid: a meta‐analysis
Ziegler, D., Nowak, H., Kempler, P., Vargha, P., & Low, P. A. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01109.x · Cited by 551
Gore, M., Brandenburg, N. A., Dukes, E., Hoffman, D. L., Tai, K.-S., & Stacey, B. (2005) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2005.04.009 · Cited by 525
Brain Magnetic Resonance Imaging Correlates of Impaired Cognition in Patients With Type 2 Diabetes
Manschot, S. M., Brands, A. M. A., van der Grond, J., Kessels, R. P. C., Algra, A., Kappelle, L. J., Biessels, G. J., & on behalf of the Utrecht Diabetic Encephalopathy Study Group (2006) · Diabetes · doi:10.2337/diabetes.55.04.06.db05-1323 · Cited by 482
Tesfaye, S., Vileikyte, L., Rayman, G., Sindrup, S. H., Perkins, B. A., Baconja, M., Vinik, A. I., Boulton, A. J. M., & Neuropathy, O. B. O. T. T. E. P. O. D. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1225 · Cited by 410
Self-citationZiegler, D., Rathmann, W., Dickhaus, T., Meisinger, C., Mielck, A., & for the KORA Study Group (2008) · Diabetes Care · doi:10.2337/dc07-1796 · Cited by 397
Sensory gating mechanisms of the thalamus
McCormick, D. A., & Bal, T. (1994) · Current Opinion in Neurobiology · doi:10.1016/0959-4388(94)90056-6 · Cited by 392
Elevated Triglycerides Correlate With Progression of Diabetic Neuropathy
Wiggin, T. D., Sullivan, K. A., Pop-Busui, R., Amato, A., Sima, A. A. F., & Feldman, E. L. (2009) · Diabetes · doi:10.2337/db08-1771 · Cited by 344
Electrical spinal-cord stimulation for painful diabetic peripheral neuropathy
Tesfaye, S., Watt, J., Benbow, S. J., Pang, K. A., Miles, J., & MacFarlane, I. A. (1996) · The Lancet · doi:10.1016/s0140-6736(96)02467-1 · Cited by 309
Self-citationDyslipidemia-Induced Neuropathy in Mice
Vincent, A. M., Hayes, J. M., McLean, L. L., Vivekanandan-Giri, A., Pennathur, S., & Feldman, E. L. (2009) · Diabetes · doi:10.2337/db09-0047 · Cited by 264
Sural nerve oxygen tension in diabetes.
Newrick, P. G., Wilson, A. J., Jakubowski, J., Boulton, A. J., & Ward, J. D. (1986) · BMJ · doi:10.1136/bmj.293.6554.1053 · Cited by 254
The Relationship Among Pain, Sensory Loss, and Small Nerve Fibers in Diabetes
Sorensen, L., Molyneaux, L., & Yue, D. K. (2006) · Diabetes Care · doi:10.2337/diacare.29.04.06.dc05-2180 · Cited by 241
An fMRI study of cerebral processing of brush-evoked allodynia in neuropathic pain patients
Schweinhardt, P., Glynn, C., Brooks, J., McQuay, H., Jack, T., Chessell, I., Bountra, C., & Tracey, I. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2006.03.024 · Cited by 196
Oyibo, S. O., Prasad, Y. D. M., Jackson, N. J., Jude, E. B., & Boulton, A. J. M. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00801.x · Cited by 194
Tesfaye, S., Harris, N., Jakubowski, J. J., Mody, C., Wilson, R. M., Rennie, I. G., & Ward, J. D. (1993) · Diabetologia · doi:10.1007/bf00400804 · Cited by 174
Self-citationEarly Involvement of the Spinal Cord in Diabetic Peripheral Neuropathy
Selvarajah, D., Wilkinson, I. D., Emery, C. J., Harris, N. D., Shaw, P. J., Witte, D. R., Griffiths, P. D., & Tesfaye, S. (2006) · Diabetes Care · doi:10.2337/dc06-0650 · Cited by 170
Self-citationCan neuroimaging studies identify pain endophenotypes in humans?
Tracey, I. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.4 · Cited by 167
Endoneurial localisation of microvascular damage in human diabetic neuropathy
Malik, R. A., Tesfaye, S., Thompson, S. D., Veves, A., Sharma, A. K., Boulton, A. J. M., & Ward, J. D. (1993) · Diabetologia · doi:10.1007/bf00402283 · Cited by 158
Self-citationSpinal-cord involvement in diabetic peripheral neuropathy
Eaton, S. E. M., Harris, N. D., Rajbhandari, S. M., Greenwood, P., Wilkinson, I. D., Ward, J. D., Griffiths, P. D., & Tesfaye, S. H. (2001) · The Lancet · doi:10.1016/s0140-6736(00)05268-5 · Cited by 152
Self-citationUnderstanding the impact of painful diabetic neuropathy
Quattrini, C., & Tesfaye, S. H. (2003) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.360 · Cited by 139
Self-citationRecent advances in the management of diabetic distal symmetrical polyneuropathy
Tesfaye, S. H. (2011) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2010.00083.x · Cited by 137
Self-citationForsblom, C. M., Sane, T., Groop, P., Tötterman, K. J., Kallio, M., Saloranta, C., Laasonen, L., Summanen, P. A., Lepäntalo, M., Laatikainen, L., et al. (1998) · Diabetologia · doi:10.1007/s001250051062 · Cited by 126
Coppini, D. V., Bowtell, P., Weng, C., Young, P. J., & Sönksen, P. H. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(99)00170-5 · Cited by 123
Gandhi, R. A., Marques, J. L. B., Selvarajah, D., Emery, C., & Tesfaye, S. H. (2010) · Diabetes Care · doi:10.2337/dc09-2314 · Cited by 105
Self-citationImpaired Skin Microvascular Reactivity in Painful Diabetic Neuropathy
Quattrini, C., Harris, N. D., Malik, R. A., & Tesfaye, S. H. (2007) · Diabetes Care · doi:10.2337/dc06-2154 · Cited by 103
Self-citationCentral nervous system involvement in diabetic neuropathy
Selvarajah, D., Wilkinson, I. D., Davies, J., Gandhi, R., & Tesfaye, S. (2011) · Current Diabetes Reports · doi:10.1007/s11892-011-0205-z · Cited by 102
Self-citationNeuropathic pain in diabetes—evidence for a central mechanism
Fischer, T. Z., & Waxman, S. G. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.90 · Cited by 99
Selvarajah, D., Wilkinson, I. D., Emery, C., Shaw, P. J., Griffiths, P. D., Gandhi, R. A., & Tesfaye, S. H. (2008) · Diabetologia · doi:10.1007/s00125-008-1139-0 · Cited by 93
Self-citationSelvarajah, D., Wilkinson, I. D., Gandhi, R. A., Griffiths, P. D., & Tesfaye, S. H. (2011) · Diabetes Care · doi:10.2337/dc10-1550 · Cited by 93
Self-citationIncreased sural nerve epineurial blood flow in human subjects with painful diabetic neuropathy
Harris, N. D., Ibrahim, S., Patel, K. A., Selmi, F., Radatz, M. W. R., Ward, J. D., Tesfaye, S. H., & Eaton, S. E. M. (2003) · Diabetologia · doi:10.1007/s00125-003-1127-3 · Cited by 70
Self-citationThalamic neuron hyperexcitability and enlarged receptive fields in the STZ model of diabetic pain
Fischer, T. Z., Tan, A. M., & Waxman, S. G. (2009) · Brain Research · doi:10.1016/j.brainres.2009.02.063 · Cited by 68
Currie, C. J., Poole, C., Woehl, A., Morgan, C. L., Cawley, S., Rousculp, M. D., Covington, M., & Peters, J. R. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.02057.x · Cited by 60
Wilson, P., Kitchener, P. D., & Snow, P. J. (1999) · Journal of Neurophysiology · doi:10.1152/jn.1999.82.4.1865 · Cited by 13
Cited by
Tesfaye, S., Wilhelm, S., Lledo, A., Schacht, A., Tölle, T., Bouhassira, D., Cruccu, G., Skljarevski, V., & Freynhagen, R. (2013) · Pain · doi:10.1016/j.pain.2013.05.043 · Cited by 311
Self-citationAndersen, S. T., Witte, D. R., Dalsgaard, E.-M., Andersen, H., Nawroth, P., Fleming, T., Jensen, T. M., Finnerup, N. B., Jensen, T. S., Lauritzen, T., et al. (2018) · Diabetes Care · doi:10.2337/dc17-2062 · Cited by 248
Gylfadottir, S. S., Christensen, D. H., Nicolaisen, S. K., Andersen, H., Callaghan, B. C., Itani, M., Khan, K. S., Kristensen, A. G., Nielsen, J. S., Sindrup, S. H., et al. (2020) · Pain · doi:10.1097/j.pain.0000000000001744 · Cited by 151
Bouhassira, D., Wilhelm, S., Schacht, A., Perrot, S., Kosek, E., Cruccu, G., Freynhagen, R., Tesfaye, S., Lledó, A., Choy, E., et al. (2014) · Pain · doi:10.1016/j.pain.2014.08.020 · Cited by 132
Self-citationAntioxidant Phytochemicals as Potential Therapy for Diabetic Complications
Akpoveso, O.-O. P., Ubah, E. E., & Obasanmi, G. (2023) · Antioxidants · doi:10.3390/antiox12010123 · Cited by 90
Metadata
- Authors
- Tesfaye, S., & Selvarajah, D.
- Venue
- Diabetes/Metabolism Research and Reviews
- Publisher
- Wiley
- Published
- 2012-01-23
- Volume
- 28
- Issue
- S1
- Pages
- 8-14
- ISSN
- 1520-7552 (ISSN-L)
- 1520-7560
- OpenAlex
- W1537164314
- Cited by
- 615
- References
- 42
- FWCI
- 23.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
